Literature DB >> 17571170

The effect of different strains of Helicobacter pylori on platelet aggregation.

Paul A Corcoran1, John C Atherton, Steve W Kerrigan, Torkel Wadstrom, Frank E Murray, Richard M Peek, Desmond J Fitzgerald, Dermont M Cox, Michael F Byrne.   

Abstract

BACKGROUND AND AIMS: Helicobacter pylori is the major causative agent in peptic ulcer disease and is strongly implicated in the development of gastric cancer. It has also been linked, less strongly, to cardiovascular disease. The mechanisms by which certain strains of H pylori induce platelet aggregation through interactions with platelet glycoprotein Ib have been previously described.
METHODS: In the present study, 21 different strains of H pylori, varying in their vacuolating toxin gene, cytotoxic-associated gene A status and other pathogenicity factors, were tested for their ability to induce platelet aggregation.
RESULTS: Ten of the 21 strains induced platelet aggregation, a response that appeared to be independent of their vacuolating toxin gene and cytotoxic-associated gene A status.
CONCLUSIONS: Platelet aggregation has been suggested to be one of the possible mechanisms involved in the effects on the cardiovascular system induced by H pylori. Our results suggest that any putative role H pylori plays in cardiovascular disease may be strain dependent. Further work to identify the H pylori factors involved in induction of platelet aggregation may allow for identification of 'higher risk' strains for cardiovascular disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17571170      PMCID: PMC2658119          DOI: 10.1155/2007/490852

Source DB:  PubMed          Journal:  Can J Gastroenterol        ISSN: 0835-7900            Impact factor:   3.522


  24 in total

1.  Platelet activation In mice and human Helicobacter pylori infection.

Authors:  J I Elizalde; J Gómez; J Panés; M Lozano; M Casadevall; J Ramírez; P Pizcueta; F Marco; F D Rojas; D N Granger; J M Piqué
Journal:  J Clin Invest       Date:  1997-09-01       Impact factor: 14.808

2.  Helicobacter pylori and chronic ITP: the discrepancy in the clinical responses to eradication therapy might be due to differences in the bacterial strains.

Authors:  Toru Takahashi; Toshiaki Yujiri; Yukio Tanizawa
Journal:  Blood       Date:  2004-07-15       Impact factor: 22.113

3.  Helicobacter pylori infection is related to atheroma in patients undergoing coronary angiography.

Authors:  N Ossei-Gerning; P Moayyedi; S Smith; D Braunholtz; J I Wilson; A T Axon; P J Grant
Journal:  Cardiovasc Res       Date:  1997-07       Impact factor: 10.787

4.  Pattern of adhesion molecule expression on vascular endothelium in Helicobacter pylori-associated antral gastritis.

Authors:  R A Hatz; G Rieder; M Stolte; E Bayerdörffer; G Meimarakis; F W Schildberg; G Enders
Journal:  Gastroenterology       Date:  1997-06       Impact factor: 22.682

5.  Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors.

Authors:  P Patel; M A Mendall; D Carrington; D P Strachan; E Leatham; N Molineaux; J Levy; C Blakeston; C A Seymour; A J Camm
Journal:  BMJ       Date:  1995-09-16

6.  Expression of adhesion molecules on human granulocytes after stimulation with Helicobacter pylori membrane proteins: comparison with membrane proteins from other bacteria.

Authors:  G Enders; W Brooks; N von Jan; N Lehn; E Bayerdörffer; R Hatz
Journal:  Infect Immun       Date:  1995-07       Impact factor: 3.441

7.  Helicobacter pylori virulence factors--one part of a big picture.

Authors:  Michael Höcker; Peter Hohenberger
Journal:  Lancet       Date:  2003-10-11       Impact factor: 79.321

8.  Helicobacter pylori-induced microvascular protein leakage in rats: role of neutrophils, mast cells, and platelets.

Authors:  I Kurose; D N Granger; D J Evans; D G Evans; D Y Graham; M Miyasaka; D C Anderson; R E Wolf; G Cepinskas; P R Kvietys
Journal:  Gastroenterology       Date:  1994-07       Impact factor: 22.682

9.  Relation of Helicobacter pylori infection and coronary heart disease.

Authors:  M A Mendall; P M Goggin; N Molineaux; J Levy; T Toosy; D Strachan; A J Camm; T C Northfield
Journal:  Br Heart J       Date:  1994-05

10.  Helicobacter pylori binds von Willebrand factor and interacts with GPIb to induce platelet aggregation.

Authors:  Michael F Byrne; Steven W Kerrigan; Paul A Corcoran; John C Atherton; Frank E Murray; Desmond J Fitzgerald; Dermot M Cox
Journal:  Gastroenterology       Date:  2003-06       Impact factor: 22.682

View more
  6 in total

Review 1.  Platelet-bacterial interactions.

Authors:  Steven W Kerrigan; Dermot Cox
Journal:  Cell Mol Life Sci       Date:  2009-11-29       Impact factor: 9.261

Review 2.  Clinical significance of Helicobacter pylori infection in patients with acute coronary syndromes: an overview of current evidence.

Authors:  Jacek Budzyński; Marek Koziński; Maria Kłopocka; Julia Maria Kubica; Jacek Kubica
Journal:  Clin Res Cardiol       Date:  2014-05-10       Impact factor: 5.460

Review 3.  Early Host Interactions That Drive the Dysregulated Response in Sepsis.

Authors:  Steven W Kerrigan; Tatyana Devine; Glenn Fitzpatrick; Jecko Thachil; Dermot Cox
Journal:  Front Immunol       Date:  2019-08-06       Impact factor: 7.561

Review 4.  Helicobacter pylori Infection and Chronic Immune Thrombocytopenia.

Authors:  Hiroaki Takeuchi; Aoi Okamoto
Journal:  J Clin Med       Date:  2022-08-17       Impact factor: 4.964

5.  Helicobacter pylori urease activates blood platelets through a lipoxygenase-mediated pathway.

Authors:  German E Wassermann; Deiber Olivera-Severo; Augusto F Uberti; Célia R Carlini
Journal:  J Cell Mol Med       Date:  2009-09-14       Impact factor: 5.310

6.  Helicobacter pylori downregulates expression of human β-defensin 1 in the gastric mucosa in a type IV secretion-dependent fashion.

Authors:  S R Patel; K Smith; D P Letley; K W Cook; A A Memon; R J M Ingram; E Staples; S Backert; A M Zaitoun; J C Atherton; K Robinson
Journal:  Cell Microbiol       Date:  2013-08-07       Impact factor: 3.715

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.